Skip to main content

Agah Ramtin's Form 4 filing

RenovoRx, Inc.RNXT · filed Nov 24, 2025

Accession no.
0001493152-25-024875
Filed
Nov 24, 2025
Trade date
Nov 21-24, 2025
Filing delay
3 days
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions. Open-market purchases total $17.6K. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Agah RamtinCIK 0001862617Director, Officer (Chief Medical Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 21, 2025Common StockPPurchaseAcquired+10,000$0.80+$8,000744,460Direct
Nov 24, 2025Common StockPPurchaseAcquired+12,000$0.80+$9,600756,460Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)